{"id":"https://openalex.org/W4377966401","doi":"https://doi.org/10.1182/bloodadvances.2023009729","title":"Real-world experience with low-dose IL-2 for children and young adults with refractory chronic graft-versus-host disease","display_name":"Real-world experience with low-dose IL-2 for children and young adults with refractory chronic graft-versus-host disease","publication_year":2023,"publication_date":"2023-05-24","ids":{"openalex":"https://openalex.org/W4377966401","doi":"https://doi.org/10.1182/bloodadvances.2023009729","pmid":"https://pubmed.ncbi.nlm.nih.gov/37603347","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10448423"},"language":"en","primary_location":{"id":"doi:10.1182/bloodadvances.2023009729","doi":"https://doi.org/10.1182/bloodadvances.2023009729","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2023009729","pdf_url":"https://ashpublications.org/bloodadvances/article-pdf/doi/10.1182/bloodadvances.2023009729/2053797/bloodadvances.2023009729.pdf","source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://ashpublications.org/bloodadvances/article-pdf/doi/10.1182/bloodadvances.2023009729/2053797/bloodadvances.2023009729.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071487748","display_name":"Holly Wobma","orcid":"https://orcid.org/0000-0001-8978-3184","observed_orcids":["https://orcid.org/0000-0001-8978-3184"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Holly Wobma","raw_affiliation_strings":["1Division of Immunology, Boston Children\u2019s Hospital, Boston, MA","Boston Children's Hospital, Boston, Massachusetts, United States"],"raw_orcid":"https://orcid.org/0000-0001-8978-3184","affiliations":[{"raw_affiliation_string":"1Division of Immunology, Boston Children\u2019s Hospital, Boston, MA","institution_ids":["https://openalex.org/I1288882113"]},{"raw_affiliation_string":"Boston Children's Hospital, Boston, Massachusetts, United States","institution_ids":["https://openalex.org/I1288882113"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063156240","display_name":"Malika A. Kapadia","orcid":"https://orcid.org/0009-0000-3959-5441","observed_orcids":["https://orcid.org/0009-0000-3959-5441"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Malika Kapadia","raw_affiliation_strings":["2Division of Hematology-Oncology, Boston Children\u2019s Hospital, Boston, MA","3Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA","Division of Hematology-Oncology, Boston Children's Hospital, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Division of Hematology-Oncology, Boston Children\u2019s Hospital, Boston, MA","institution_ids":["https://openalex.org/I1288882113"]},{"raw_affiliation_string":"3Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Division of Hematology-Oncology, Boston Children's Hospital, United States","institution_ids":["https://openalex.org/I1288882113"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045479163","display_name":"Haesook T. Kim","orcid":"https://orcid.org/0000-0003-4889-6849","observed_orcids":["https://orcid.org/0000-0003-4889-6849"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Haesook T. Kim","raw_affiliation_strings":["4Department of Data Science, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Department of Data Science, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042314711","display_name":"Francesca Alvarez Calderon","orcid":"https://orcid.org/0000-0001-5620-8431","observed_orcids":["https://orcid.org/0000-0001-5620-8431"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Francesca Alvarez-Calderon","raw_affiliation_strings":["2Division of Hematology-Oncology, Boston Children\u2019s Hospital, Boston, MA","3Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":"https://orcid.org/0000-0001-5620-8431","affiliations":[{"raw_affiliation_string":"2Division of Hematology-Oncology, Boston Children\u2019s Hospital, Boston, MA","institution_ids":["https://openalex.org/I1288882113"]},{"raw_affiliation_string":"3Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066615406","display_name":"Susanne H.C. Baumeister","orcid":"https://orcid.org/0000-0003-3846-5156","observed_orcids":["https://orcid.org/0000-0003-3846-5156"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susanne H. C. Baumeister","raw_affiliation_strings":["2Division of Hematology-Oncology, Boston Children\u2019s Hospital, Boston, MA","3Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Division of Hematology-Oncology, Boston Children\u2019s Hospital, Boston, MA","institution_ids":["https://openalex.org/I1288882113"]},{"raw_affiliation_string":"3Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110543173","display_name":"Christine Duncan","orcid":"https://orcid.org/0000-0002-2090-4897","observed_orcids":["https://orcid.org/0000-0002-2090-4897"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christine Duncan","raw_affiliation_strings":["2Division of Hematology-Oncology, Boston Children\u2019s Hospital, Boston, MA","3Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Division of Hematology-Oncology, Boston Children\u2019s Hospital, Boston, MA","institution_ids":["https://openalex.org/I1288882113"]},{"raw_affiliation_string":"3Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020118706","display_name":"Suzanne J. Forrest","orcid":"https://orcid.org/0000-0002-9797-7947","observed_orcids":["https://orcid.org/0000-0002-9797-7947"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Suzanne Forrest","raw_affiliation_strings":["2Division of Hematology-Oncology, Boston Children\u2019s Hospital, Boston, MA","3Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":"https://orcid.org/0000-0002-9797-7947","affiliations":[{"raw_affiliation_string":"2Division of Hematology-Oncology, Boston Children\u2019s Hospital, Boston, MA","institution_ids":["https://openalex.org/I1288882113"]},{"raw_affiliation_string":"3Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024557302","display_name":"Lev Gorfinkel","orcid":"https://orcid.org/0000-0002-8781-2276","observed_orcids":["https://orcid.org/0000-0002-8781-2276"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lev Gorfinkel","raw_affiliation_strings":["2Division of Hematology-Oncology, Boston Children\u2019s Hospital, Boston, MA","3Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":"https://orcid.org/0000-0002-8781-2276","affiliations":[{"raw_affiliation_string":"2Division of Hematology-Oncology, Boston Children\u2019s Hospital, Boston, MA","institution_ids":["https://openalex.org/I1288882113"]},{"raw_affiliation_string":"3Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003107485","display_name":"Jennifer T. Huang","orcid":"https://orcid.org/0000-0001-6191-7486","observed_orcids":["https://orcid.org/0000-0001-6191-7486"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Huang","raw_affiliation_strings":["1Division of Immunology, Boston Children\u2019s Hospital, Boston, MA","Boston Children's Hospital, Boston, Massachusetts, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Immunology, Boston Children\u2019s Hospital, Boston, MA","institution_ids":["https://openalex.org/I1288882113"]},{"raw_affiliation_string":"Boston Children's Hospital, Boston, Massachusetts, United States","institution_ids":["https://openalex.org/I1288882113"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008479139","display_name":"Leslie Lehmann","orcid":"https://orcid.org/0000-0001-5558-4830","observed_orcids":["https://orcid.org/0000-0001-5558-4830"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leslie E. Lehmann","raw_affiliation_strings":["2Division of Hematology-Oncology, Boston Children\u2019s Hospital, Boston, MA","3Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Division of Hematology-Oncology, Boston Children\u2019s Hospital, Boston, MA","institution_ids":["https://openalex.org/I1288882113"]},{"raw_affiliation_string":"3Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058731290","display_name":"Hojun Li","orcid":"https://orcid.org/0000-0002-8129-0390","observed_orcids":["https://orcid.org/0000-0002-8129-0390"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hojun Li","raw_affiliation_strings":["2Division of Hematology-Oncology, Boston Children\u2019s Hospital, Boston, MA","3Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Division of Hematology-Oncology, Boston Children\u2019s Hospital, Boston, MA","institution_ids":["https://openalex.org/I1288882113"]},{"raw_affiliation_string":"3Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066561471","display_name":"Marc A. Schwartz","orcid":"https://orcid.org/0000-0003-3869-0150","observed_orcids":["https://orcid.org/0000-0003-3869-0150"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marc Schwartz","raw_affiliation_strings":["2Division of Hematology-Oncology, Boston Children\u2019s Hospital, Boston, MA","3Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":"https://orcid.org/0000-0003-3869-0150","affiliations":[{"raw_affiliation_string":"2Division of Hematology-Oncology, Boston Children\u2019s Hospital, Boston, MA","institution_ids":["https://openalex.org/I1288882113"]},{"raw_affiliation_string":"3Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029390145","display_name":"John Koreth","orcid":"https://orcid.org/0000-0002-7428-1330","observed_orcids":["https://orcid.org/0000-0002-7428-1330"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Koreth","raw_affiliation_strings":["5Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008718116","display_name":"Jerome Ritz","orcid":"https://orcid.org/0000-0001-5526-4669","observed_orcids":["https://orcid.org/0000-0001-5526-4669"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jerome Ritz","raw_affiliation_strings":["5Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA","Harvard Medical School, Boston, Massachusetts, United States"],"raw_orcid":"https://orcid.org/0000-0001-5526-4669","affiliations":[{"raw_affiliation_string":"5Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Harvard Medical School, Boston, Massachusetts, United States","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027478389","display_name":"Leslie S. Kean","orcid":"https://orcid.org/0000-0003-0475-3926","observed_orcids":["https://orcid.org/0000-0003-0475-3926"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leslie S. Kean","raw_affiliation_strings":["2Division of Hematology-Oncology, Boston Children\u2019s Hospital, Boston, MA","3Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Division of Hematology-Oncology, Boston Children\u2019s Hospital, Boston, MA","institution_ids":["https://openalex.org/I1288882113"]},{"raw_affiliation_string":"3Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069087536","display_name":"Jennifer Whangbo","orcid":"https://orcid.org/0000-0002-5759-2532","observed_orcids":["https://orcid.org/0000-0002-5759-2532"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jennifer S. Whangbo","raw_affiliation_strings":["2Division of Hematology-Oncology, Boston Children\u2019s Hospital, Boston, MA","3Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":"https://orcid.org/0000-0002-5759-2532","affiliations":[{"raw_affiliation_string":"2Division of Hematology-Oncology, Boston Children\u2019s Hospital, Boston, MA","institution_ids":["https://openalex.org/I1288882113"]},{"raw_affiliation_string":"3Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5069087536"],"corresponding_institution_ids":["https://openalex.org/I1288882113","https://openalex.org/I4210117453"],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":{"value":3000,"currency":"USD","value_usd":3000},"fwci":5.3081,"has_fulltext":true,"cited_by_count":24,"citation_normalized_percentile":{"value":0.96656683,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"7","issue":"16","first_page":"4647","last_page":"4657"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11725","display_name":"Immunodeficiency and Autoimmune Disorders","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-graft-versus-host-disease","display_name":"chronic graft-versus-host disease","score":0.9509999752044678},{"id":"https://openalex.org/keywords/low-dose-il-2","display_name":"low-dose interleukin-2","score":0.9670000076293945},{"id":"https://openalex.org/keywords/steroid-refractory-cgvhd","display_name":"steroid-refractory cGVHD","score":0.8709999918937683},{"id":"https://openalex.org/keywords/pediatric-patients","display_name":"pediatric patients","score":0.6079999804496765},{"id":"https://openalex.org/keywords/young-adults","display_name":"young adults","score":0.7350000143051147},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.9760000109672546},{"id":"https://openalex.org/keywords/cd4-t-cells","display_name":"CD4+ T cells","score":0.8059999942779541},{"id":"https://openalex.org/keywords/steroid-sparing-therapy","display_name":"steroid-sparing therapy","score":0.871999979019165},{"id":"https://openalex.org/keywords/corticosteroid-weaning","display_name":"corticosteroid weaning","score":0.9300000071525574},{"id":"https://openalex.org/keywords/real-world-experience","display_name":"real-world experience","score":0.7300000190734863},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.4359999895095825}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8135820031166077},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.6500738263130188},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5839065313339233},{"id":"https://openalex.org/C2779972918","wikidata":"https://www.wikidata.org/wiki/Q1194520","display_name":"Graft-versus-host disease","level":3,"score":0.5303605198860168},{"id":"https://openalex.org/C2780073493","wikidata":"https://www.wikidata.org/wiki/Q7523837","display_name":"Single Center","level":2,"score":0.5021343231201172},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.48291847109794617},{"id":"https://openalex.org/C205545832","wikidata":"https://www.wikidata.org/wiki/Q17156455","display_name":"Young adult","level":2,"score":0.45164841413497925},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.43967169523239136},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.43419772386550903},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.43189772963523865},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3538476228713989},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3108574151992798},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.08318638801574707},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006086","descriptor_name":"Graft vs Host Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006086","descriptor_name":"Graft vs Host Disease","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007223","descriptor_name":"Infant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1182/bloodadvances.2023009729","doi":"https://doi.org/10.1182/bloodadvances.2023009729","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2023009729","pdf_url":"https://ashpublications.org/bloodadvances/article-pdf/doi/10.1182/bloodadvances.2023009729/2053797/bloodadvances.2023009729.pdf","source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10448423","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10448423","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10448423/pdf/main.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Adv","raw_type":"Text"},{"id":"pmid:37603347","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37603347","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood advances","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1182/bloodadvances.2023009729","doi":"https://doi.org/10.1182/bloodadvances.2023009729","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2023009729","pdf_url":"https://ashpublications.org/bloodadvances/article-pdf/doi/10.1182/bloodadvances.2023009729/2053797/bloodadvances.2023009729.pdf","source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[{"id":"https://openalex.org/G3084057834","display_name":null,"funder_award_id":"K08-DK123414","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"},{"id":"https://openalex.org/G3352185070","display_name":"Post Graduate Training in Pediatric Oncology","funder_award_id":"T32CA082086","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7075883853","display_name":"Regulating proliferation and differentiation of erythroid progenitors","funder_award_id":"7k08dk123414-05","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G7844266926","display_name":"Immune Modulation After Allogeneic HCT","funder_award_id":"P01CA229092","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000878905","display_name":"Molecular Basis of Allergic and Immunologic Disease","funder_award_id":"T32AI007512","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G9000888270","display_name":"Mechanisms and Therapy of Chronic Graft-vs.-Host Disease","funder_award_id":"P01HL158505","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G9000911320","display_name":"Novel Biologic Therapies for GVHD","funder_award_id":"R01HL095791","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"}],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320308573","display_name":"Gilead Sciences","ror":"https://ror.org/056546b03"},{"id":"https://openalex.org/F4320316659","display_name":"bluebird bio","ror":"https://ror.org/04vaq9436"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337338","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"},{"id":"https://openalex.org/F4320337357","display_name":"National Institute of Diabetes and Digestive and Kidney Diseases","ror":"https://ror.org/00adh9b73"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4377966401.pdf","grobid_xml":"https://content.openalex.org/works/W4377966401.grobid-xml"},"referenced_works_count":36,"referenced_works":["https://openalex.org/W1965249571","https://openalex.org/W1977680996","https://openalex.org/W1997942715","https://openalex.org/W2005604237","https://openalex.org/W2015376897","https://openalex.org/W2031251938","https://openalex.org/W2049808194","https://openalex.org/W2054710330","https://openalex.org/W2086030126","https://openalex.org/W2100088787","https://openalex.org/W2109346271","https://openalex.org/W2206276344","https://openalex.org/W2338482953","https://openalex.org/W2379365975","https://openalex.org/W2537391848","https://openalex.org/W2548653188","https://openalex.org/W2549544658","https://openalex.org/W2780122844","https://openalex.org/W2789780246","https://openalex.org/W2895456163","https://openalex.org/W2901041673","https://openalex.org/W2930008898","https://openalex.org/W2932759555","https://openalex.org/W2970988642","https://openalex.org/W2973404796","https://openalex.org/W3016619242","https://openalex.org/W3034963696","https://openalex.org/W3040373516","https://openalex.org/W3155568211","https://openalex.org/W3180640300","https://openalex.org/W3184315968","https://openalex.org/W4210380896","https://openalex.org/W4281777617","https://openalex.org/W4283812311","https://openalex.org/W4291993884","https://openalex.org/W4401512633"],"related_works":["https://openalex.org/W2912269012","https://openalex.org/W2970988642","https://openalex.org/W2559267192","https://openalex.org/W2338482953","https://openalex.org/W4281777617","https://openalex.org/W4295993300","https://openalex.org/W2544046881","https://openalex.org/W2101913764","https://openalex.org/W4225010683","https://openalex.org/W4388293062"],"abstract_inverted_index":{"The":[0,102,152,180],"majority":[1],"of":[2,50,54,80,107,119,132,146,155,191,223,228],"patients":[3,81,166,186,210],"with":[4,44,65,82,204,217,249,259],"chronic":[5],"graft-versus-host":[6],"disease":[7],"(cGVHD)":[8],"are":[9],"steroid":[10],"refractory":[11],"(SR),":[12],"creating":[13],"a":[14,76,99,117,130,144,218,245,250],"need":[15],"for":[16],"safe":[17],"and":[18,52,71,142,256],"effective":[19],"therapies.":[20,151],"Subcutaneous":[21],"low-dose":[22],"interleukin-2":[23],"(LD":[24],"IL-2),":[25],"which":[26],"preferentially":[27,215],"expands":[28],"CD4+":[29,231],"regulatory":[30],"T":[31,233],"cells":[32,234],"(Tregs),":[33],"has":[34],"been":[35],"evaluated":[36],"in":[37,48,68,184,206,225,254],"5":[38],"clinical":[39],"trials":[40],"at":[41,84,105,116,138],"our":[42,85],"center":[43,86],"partial":[45],"responses":[46,205],"(PR)":[47],"\u223c50%":[49],"adults":[51,258],"82%":[53],"children":[55,70,255],"by":[56,237],"week":[57],"8.":[58],"We":[59,74],"now":[60],"report":[61],"additional":[62],"real-world":[63],"experience":[64],"LD":[66,89,108,139,156,242],"IL-2":[67,90,109,140,157,243],"15":[69],"young":[72,257],"adults.":[73],"conducted":[75],"retrospective":[77],"chart":[78],"review":[79],"SR-cGVHD":[83],"who":[87,187],"received":[88,143,167,188],"from":[91,122],"August":[92],"2016":[93],"to":[94,230],"July":[95],"2022":[96],"not":[97],"on":[98,240],"research":[100],"trial.":[101],"median":[103,118,131,145,153,219],"age":[104],"start":[106,141],"was":[110,159,193],"10.4":[111],"years":[112],"(range,":[113,125,134,148,162,235],"1.2-23.2":[114],"years)":[115],"234":[120],"days":[121,161],"cGVHD":[123],"diagnosis":[124],"11-542":[126],"days).":[127,164],"Patients":[128],"had":[129],"2.5":[133],"1-3)":[135],"active":[136],"organs":[137],"3":[147],"1-5)":[149],"prior":[150],"duration":[154],"therapy":[158,192],"462":[160],"8-1489":[163],"Most":[165,209],"1":[168],"\u00d7":[169],"106":[170],"IU/m2":[171],"per":[172],"day.":[173],"There":[174],"were":[175],"no":[176],"serious":[177],"adverse":[178],"effects.":[179],"overall":[181],"response":[182,252],"rate":[183,253],"13":[185],">4":[189],"weeks":[190,239],"85%":[194],"(complete":[195],"response,":[196],"n":[197,201],"=":[198,202],"5;":[199],"PR,":[200],"6)":[203],"diverse":[207],"organs.":[208],"significantly":[211],"weaned":[212],"corticosteroids.":[213],"Tregs":[214,229],"expanded":[216],"peak":[220],"fold":[221],"increase":[222],"2.8":[224],"the":[226],"ratio":[227],"conventional":[232],"2.0-19.8)":[236],"8":[238],"therapy.":[241],"is":[244],"well-tolerated,":[246],"steroid-sparing":[247],"agent":[248],"high":[251],"SR-cGVHD.":[260]},"counts_by_year":[{"year":2026,"cited_by_count":9},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":5}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-05-25T00:00:00"}